Cargando…
Wogonoside Attenuates Cutaneous Squamous Cell Carcinoma by Reducing Epithelial–Mesenchymal Transition/Invasion and Cancer Stem-Like Cell Property
PURPOSE: Cutaneous squamous cell carcinoma (cSCC) is the most common second basal cell carcinoma in our population. Wogonoside, the main in vivo metabolite of wogonin, possesses anti-inflammatory, anti-angiogenesis and anti-cancer activities. Nevertheless, the effectiveness of wogonoside therapy on...
Autores principales: | Wang, Xiuyong, Chang, Yuan, Gao, Ming, Zhang, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553668/ https://www.ncbi.nlm.nih.gov/pubmed/33116592 http://dx.doi.org/10.2147/OTT.S251806 |
Ejemplares similares
-
Tumor budding of cervical squamous cell carcinoma: epithelial-mesenchymal transition-like cancer stem cells?
por: Zheng, Shaoqiu, et al.
Publicado: (2022) -
A Hybrid Epithelial to Mesenchymal Transition in Ex Vivo Cutaneous Squamous Cell Carcinoma Tissues
por: Pulford, Christopher S., et al.
Publicado: (2022) -
Epithelial-mesenchymal transition related to bone invasion in oral squamous cell carcinoma
por: Vanini, Jaqueline Vaz, et al.
Publicado: (2022) -
Epithelial-mesenchymal Transition and Cell Invasion
por: Son, Hwajin, et al.
Publicado: (2010) -
Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells
por: Park, So-Yeon, et al.
Publicado: (2015)